New Data Demonstrate Efficacy of ClarityMD OTC Acne System

June 11, 2014

Newly published data show the efficacy of Envy Medical's ClarityMD acne system.
Results of a clinical study designed by Envy, demonstrate that ClarityMD is effective in quickly and gently clearing both inflammatory and non-inflammatory acne lesions. Findings appear in the June edition of the "Journal of Drugs in Dermatology." On average, 59% of acne in subjects was cleared in the first seven days; in 14 days there was a 91.6% reduction in acne. Participants' skin had virtually complete acne clearance of 98.5% over the six-week study, according to Envy. There was more than a 56% reduction in non-inflammatory lesions over the six-week period.  
The two-step ClarityMD system combines the potent combination of salicylic acid, bakuchiol, and bisabolol in a Deep Pore Cleanser and Clarifying Gel to treat acne in two simple steps, the company says. It also contains anti-aging ingredients and exfoliants such as Glycolic acid to help skin to look and feel better immediately and increase radiance over time.  
According to Ashish C. Bhatia, MD, FAAD, lead author of the study and Medical Director for Dermatologic Research at the DuPage Medical Group in Naperville, IL, “This all adds up to a highly effective new tool for treating acne, that also meets the demands of adult acne sufferers who want a skincare regimen that will clear and prevent acne while actually improving the tone and texture of skin.”

Facebook Comments

Register

We’re glad to see you’re enjoying PracticalDermatology…
but how about a more personalized experience?

Register for free